Market Currents
J&J (JNJ) +1.5% as it receives a trio of upgrades, including one from JPM for the first time...
-
Wednesday, June 13, 2012, 9:20 AM ETJ&J (JNJ) +1.5% as it receives a trio of upgrades, including one from JPM for the first time in four years. The bank raises J&J to to "overweight" from "neutral," citing the company's recently launched cancer, hepatitis and HIV drugs. Meanwhile, Jefferies increases J&J to "buy" and Raymond James to "outperform." (see also)
Other date
Latest Investing Ideas
